Clinical Trials Directory

Trials / Unknown

UnknownNCT01189721

Effect of Propofol on Remifentanil-induced Postoperative Hyperalgesia in Patients Undergoing Thyroid Surgery

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
84 (estimated)
Sponsor
Gangnam Severance Hospital · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesize that propofol infusion during surgery can affect the remifentanil hyperalgesia compared to sevoflurane inhalation.The outcome will be measured by a verbal numerical rating score (VNRS) and mechanical punctuating pain by electronic von frey filament.

Conditions

Interventions

TypeNameDescription
DRUGpropofol, sevofluraneRemifentanil will be infused intraoperatively at 0.2 ㎍/㎏/min (group1 and 2) group 1 (Active Comparator, sevoflurane)will be infused propofol intraoperatively. group 2(Experimental, propofol) will be inhaled sevoflurane intraoperatively.

Timeline

Start date
2010-08-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2010-08-27
Last updated
2010-08-27

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01189721. Inclusion in this directory is not an endorsement.

Effect of Propofol on Remifentanil-induced Postoperative Hyperalgesia in Patients Undergoing Thyroid Surgery (NCT01189721) · Clinical Trials Directory